Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: the Effect of Formulation on Anxiety in Autist Childre A Randomized Controlled Trial Assesses Spirulina Syrup Plus Risperidone in Children With Non-idiopathic Autism. Anxiety is Measured Using the SCAS (Parent Version) Via Daily Online Surveys for One Week and Throughout a 3-month Follow-up Period. [NA]

View source ↗

Summary

This study protocol outlines a randomized controlled trial to evaluate whether spirulina syrup plus risperidone affects anxiety in children aged 3 to 7 with mil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)
  • spirulina syrup (spirulina)

Snippet

Sponsor: Shahid Sadoughi University of Medical Sciences and Health Services | Conditions: Age 3 to 7 Years, Mild Autism Spectrum | NA | Status: NOT_YET_RECRUITING